"Uncovering the Diverse Subtypes and Blood Markers of Long Covid for Potential Cure"

A study led by Imperial College London has identified five different subtypes of Long Covid, shedding light on the causes of ongoing symptoms such as fatigue and brain fog. The research suggests that existing drugs for conditions like arthritis could potentially be effective against Long Covid, and new human trials will focus on this. The study indicates that Long Covid is caused by post-viral inflammation and reveals the complexity of the condition, emphasizing the need for specific tests and treatments tailored to the different subtypes. This discovery offers hope for the estimated 65 million people worldwide suffering from Long Covid and could lead to a better understanding and management of the condition.